IL6 and viral infectious disease: Moreover, the inhibitory effects of baricitinib on interferon-gamma, which has a broad-spectrum antiviral activity at multiple stages (24), might result in a hypothetical negative impact when added to the analogous effects in the defense against viral infections of IL-6 blockade.